Cargando…
Circulating Biomarkers for Early Stage Non-Small Cell Lung Carcinoma Detection: Supplementation to Low‐Dose Computed Tomography
Lung cancer is currently the leading cause of cancer death in both developing and developed countries. Given that lung cancer has poor prognosis in later stages, it is essential to achieve an early diagnosis to maximize patients’ overall survival. Non-small cell lung cancer (NSCLC) is the most commo...
Autores principales: | Kan, Chin Fung Kelvin, Unis, Graham D., Li, Luke Z., Gunn, Susan, Li, Li, Soyer, H. Peter, Stark, Mitchell S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8099172/ https://www.ncbi.nlm.nih.gov/pubmed/33968710 http://dx.doi.org/10.3389/fonc.2021.555331 |
Ejemplares similares
-
Differential Diagnosis of a Case of Dercum’s Disease with Possible
Familial Involvement and Review of Literature
por: Li, Luke Z., et al.
Publicado: (2021) -
Radiation Induced Lymphopenia Is Associated With the Effective Dose to the Circulating Immune Cells in Breast Cancer
por: Chen, Fang, et al.
Publicado: (2022) -
Prognostic Value of Postoperative Circulating Tumor DNA in Patients With Early- and Intermediate-Stage Hepatocellular Carcinoma
por: Ye, Ke, et al.
Publicado: (2022) -
Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma
por: Yang, Mingwei, et al.
Publicado: (2021) -
Circulating Glycan Monosaccharide Composite-Based Biomarker Diagnoses Colorectal Cancer at Early Stages and Predicts Prognosis
por: Li, Haoran, et al.
Publicado: (2022)